How to use capmatinib and precautions

Capmatinib is a targeted therapy drug used to treat MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC). Before using capmatinib, patients and doctors should understand detailed usage and related precautions to ensure the best efficacy of the drug while minimizing possible risks and adverse reactions.

1. How to use:

Dosage and Administration: The dosage of capmatinib is usually determined by a physician based on factors such as the patient's weight, liver function, and overall health. Patients should take capmatinib by mouth at the same time every day strictly in accordance with the doctor's recommendations, and can be taken with or without food.

Regular monitoring: Before starting treatment, patients need to undergo comprehensive pathology and genetic testing to confirm the presence ofMETexon14 skipping mutations. During treatment, doctors will regularly monitor the patient's biological markers and imaging examinations to evaluate the efficacy of the drug and the patient's overall condition.

Continuous treatment: Capmatinib usually requires continuous use, and patients should continue treatment according to the doctor's prescription. During treatment, doctors may adjust the dosage or adopt other corresponding treatment strategies based on the patient's condition and drug tolerance.

2. Notes:

Work closely with doctors: During the use of capmatinib, patients should work closely with their doctors and promptly report any discomfort and changes in symptoms. The doctor will adjust the treatment plan based on patient feedback and monitoring results to ensure the best treatment effect.

Management of adverse reactions: Capmatinib may cause some adverse reactions, including but not limited to fatigue, nausea, vomiting, diarrhea, rash, etc. Patients should be aware of possible adverse reactions and report them to their doctor promptly. Your doctor will prescribe appropriate management measures, which may include adjusting dosage, suspending medication, or using other supportive care.

Drug Interactions: Before starting treatment with capmatinib, patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter drugs, and supplements. Certain drugs may interact with capmatinib, affecting the drug's efficacy or increasing the risk of adverse reactions.

Precautions for pregnant and lactating women: Capmatinib may have adverse effects on the fetus, so female patients must take effective contraceptive measures during treatment to prevent pregnancy. Female patients should avoid breastfeeding during treatment.

Regular follow-up: During capmatinib treatment, patients need to receive regular medical examinations and follow-up visits to monitor the progression of the disease and evaluate survival status. Follow-up visits also provide doctors with the opportunity to adjust treatment plans to ensure optimal results.

Follow the instructions for use: Patients should carefully read and follow the instructions for use of the drug when using capmatinib, including dosage, administration, adverse reactions and other relevant information.

Capmatinib is an important targeted therapy drug that provides an individualized and targeted treatment option for METexon14skipping mutationNSCLC patients. However, when using capmatinib, patients need to closely cooperate with their doctor's monitoring and treatment plan, and understand and follow relevant precautions to ensure optimal efficacy of the drug and minimize potential risks. Only when used rationally under the guidance of doctors can capmatinib exert its maximum therapeutic potential and bring better quality of life and prognosis to patients.

Capmatinib is not yet available in China, so patients cannot purchase it domestically yet and need to purchase it through overseas channels. Currently, there are Hong Kong version of original drugs and foreign original drugs and generic drugs. The price of Hong Kong version of original drugs is about 35,000 yuan. The overseas original drugs are mainly European version of original drugs, and the price is more than 50,000 yuan, so original drugs are still relatively expensive. Generic drugs on the market abroad are much cheaper, mainly Laos generic drugs, the price is around 3,000 to 4,000 yuan, and the ingredients of original drugs and generic drugs are basically the same.